IP Library › Patent Application 61591473
Patent Application Provisional Small
App. No. 61/591,473 · Confirmation No. 9559

USING STROMAL MCT4 AS A MARKER OF THE REVERSE WARBURG EFFECT TO IDENTIFY HIGH-RISK CANCER PATIENTS THAT WILL BENEFIT FROM MONOCARBOXYLATE TRANSPORTER (MCT) INHIBITOR THERAPY

Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2012-02-16 APP.FILE.REC Filing Receipt 3 View
2012-01-27 SPEC Specification 1 View
2012-01-27 ABST Abstract 1 View
2012-01-27 SPEC Specification 22 View
2012-01-27 CLM Claims 5 View
2012-01-27 DRW Drawings-only black and white line drawings 8 View
2012-01-27 APPENDIX Appendix to the specification 4 View
2012-01-27 TR.PROV Provisional Cover Sheet (SB16) 3 View
2012-01-27 ADS Application Data Sheet 4 View
2012-01-27 WFEE Fee Worksheet (SB06) 2 View
2012-01-27 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
61/591,473
Filed
2012-01-27